Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Advanced Melanoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Advanced Melanoma

Journal Scan / Research · April 17, 2023

Surveillance With Routine FDG PET–CT for the Detection of Early Recurrence in Patients With Stage IIB–IIID Cutaneous Melanoma

Annals of Surgical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Surgical Oncology
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients
Ann. Surg. Oncol 2023 Apr 01;30(4)2377-2388, NM Helvind, MB Weitemeyer, AH Chakera, HW Hendel, E Ellebæk, IM Svane, MW Kjærskov, S Bojesen, H Skyum, SK Petersen, L Bastholt, C Johansen, PE Bidstrup, LR Hölmich

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading